Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset

Bone Marrow Transplantation volume 45, pages 1540–1545 (2010)Cite this article

Subjects

Abstract

Acute GVHD (aGVHD) is an important risk factor for predicting the incidence or severity of chronic GVHD (cGVHD). Transplant outcome can be influenced by the onset time of aGVHD in patients who have received allogeneic PBSC transplants (PBSCTs). The medical records of 134 patients who survived more than 3 months after myeloablative allogeneic PBSCT were retrospectively reviewed. In all, 38 patients (28.4%) developed grade II–IV aGVHD before day +28 (early aGVHD) and 25 patients (18.7%) after day +28 (late aGVHD). The 5-year cumulative incidence of cGVHD was 78.9% in the early-aGVHD group and 56.6% in the late-aGVHD group (P=0.034). The 5-year OS was 51.0% for the early-aGVHD and 80.8% for the late-aGVHD group (P=0.406). Infection was the primary cause of death for the early-aGVHD group (51.4 vs 16.7%, P=0.017), whereas relapse of the primary disease was higher among the patients with late aGVHD, although this was statistically insignificant (58.3 vs 25.7%, P=0.309). In a multivariate analysis, early aGVHD was identified as a risk factor for developing cGVHD (hazard ratio (HR) 2.278, P=0.004). The development of aGVHD early after allogeneic PBSCT increased the risk of cGVHD and infection-related death rate when compared with the late onset of aGVHD.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Welniak LA, Blazar BR, Murphy WJ . Immunobiology of allogeneic hematopoietic stem cell transplantation. Annu Rev Immunol 2007; 25: 139–170.

    Article  CAS  PubMed  Google Scholar 

  2. Sullivan KM, Parkman R . The pathophysiology and treatment of graft-versus-host disease. Clin Haematol 1983; 12: 775–789.

    Article  CAS  PubMed  Google Scholar 

  3. Atkinson K, Horowitz MM, Gale RP, van Bekkum DW, Gluckman E, Good RA et al. Risk factors for chronic graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Blood 1990; 75: 2459–2464.

    CAS  PubMed  Google Scholar 

  4. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH . Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685–3691.

    Article  CAS  PubMed  Google Scholar 

  5. Lee SJ . New approaches for preventing and treating chronic graft-versus-host disease. Blood 2005; 105: 4200–4206.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Weisdorf DJ . Chronic graft-versus-host disease: where is promise for the future? Leukemia 2005; 19: 1532–1535.

    Article  CAS  PubMed  Google Scholar 

  7. Couriel DR, Saliba RM, Giralt S, Khouri I, Andersson B, de Lima M et al. Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation. Biol Blood Marrow Transplant 2004; 10: 178–185.

    Article  PubMed  Google Scholar 

  8. Mielcarek M, Martin PJ, Leisenring W, Flowers ME, Maloney DG, Sandmaier BM et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 2003; 102: 756–762.

    Article  CAS  PubMed  Google Scholar 

  9. Saliba RM, de Lima M, Giralt S, Andersson B, Khouri IF, Hosing C et al. Hyperacute GVHD: risk factors, outcomes, and clinical implications. Blood 2007; 109: 2751–2758.

    CAS  PubMed  Google Scholar 

  10. Williamson E, Garside P, Bradley JA, Mowat AM . IL-12 is a central mediator of acute graft-versus-host disease in mice. J Immunol 1996; 157: 689–699.

    CAS  PubMed  Google Scholar 

  11. Krenger W, Cooke KR, Crawford JM, Sonis ST, Simmons R, Pan L et al. Transplantation of polarized type 2 donor T cells reduces mortality caused by experimental graft-versus-host disease. Transplantation 1996; 62: 1278–1285.

    Article  CAS  PubMed  Google Scholar 

  12. Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825–828.

    CAS  PubMed  Google Scholar 

  13. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.

    Article  CAS  PubMed  Google Scholar 

  14. Bacigalupo A, Lamparelli T, Bruzzi P, Guidi S, Alessandrino PE, di Bartolomeo P et al. Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO). Blood 2001; 98: 2942–2947.

    Article  CAS  PubMed  Google Scholar 

  15. Giaccone L, Martin P, Carpenter P, Moravec C, Hooper H, Funke VA et al. Safety and potential efficacy of low-dose methotrexate for treatment of chronic graft-versus-host disease. Bone Marrow Transplant 2005; 36: 337–341.

    Article  CAS  PubMed  Google Scholar 

  16. Chakraverty R, Sykes M . The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia. Blood 2007; 110: 9–17.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Ferrara JL . Cellular and cytokine effectors of acute graft versus host disease. Int J Hematol 2002; 76 (Suppl 1): 195–198.

    Article  PubMed  Google Scholar 

  18. Diaconescu R, Flowers CR, Storer B, Sorror ML, Maris MB, Maloney DG et al. Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors. Blood 2004; 104: 1550–1558.

    Article  CAS  PubMed  Google Scholar 

  19. Sun Y, Tawara I, Toubai T, Reddy P . Pathophysiology of acute graft-versus-host disease: recent advances. Transl Res 2007; 150: 197–214.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Reddy P, Ferrara JL . Immunobiology of acute graft-versus-host disease. Blood Rev 2003; 17: 187–194.

    Article  PubMed  Google Scholar 

  21. Duffner UA, Maeda Y, Cooke KR, Reddy P, Ordemann R, Liu C et al. Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease. J Immunol 2004; 172: 7393–7398.

    Article  CAS  PubMed  Google Scholar 

  22. Matte CC, Liu J, Cormier J, Anderson BE, Athanasiadis I, Jain D et al. Donor APCs are required for maximal GVHD but not for GVL. Nat Med 2004; 10: 987–992.

    Article  CAS  PubMed  Google Scholar 

  23. Chan GW, Gorgun G, Miller KB, Foss FM . Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 170–176.

    Article  PubMed  Google Scholar 

  24. Remberger M, Jaksch M, Uzunel M, Mattsson J . Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantation. Eur J Haematol 2003; 70: 384–391.

    Article  CAS  PubMed  Google Scholar 

  25. Nishioka C, Ikezoe T, Togitani K, Yokoyama A . Fludarabine induces growth arrest and apoptosis of cytokine- or alloantigen-stimulated peripheral blood mononuclear cells, and decreases production of Th1 cytokines via inhibition of nuclear factor kappaB. Bone Marrow Transplant 2008; 41: 303–309.

    Article  CAS  PubMed  Google Scholar 

  26. Shlomchik WD, Couzens MS, Tang CB, McNiff J, Robert ME, Liu J et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999; 285: 412–415.

    Article  CAS  PubMed  Google Scholar 

  27. Zhang Y, Shlomchik WD, Joe G, Louboutin JP, Zhu J, Rivera A et al. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease. J Immunol 2002; 169: 7111–7118.

    Article  CAS  PubMed  Google Scholar 

  28. Schmaltz C, Alpdogan O, Muriglan SJ, Kappel BJ, Rotolo JA, Ricchetti ET et al. Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 2003; 101: 2440–2445.

    Article  CAS  PubMed  Google Scholar 

  29. Michalek J, Kocak I, Fait V, Zaloudik J, Hajek R . Detection and long-term in vivo monitoring of individual tumor-specific T cell clones in patients with metastatic melanoma. J Immunol 2007; 178: 6789–6795.

    Article  CAS  PubMed  Google Scholar 

  30. Martino R, Iacobelli S, Brand R, Jansen T, van Biezen A, Finke J et al. Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes. Blood 2006; 108: 836–846.

    Article  CAS  PubMed  Google Scholar 

  31. Chae YS, Sohn SK, Kim JG, Cho YY, Moon JH, Shin HJ et al. New myeloablative conditioning regimen with fludarabine and busulfan for allogeneic stem cell transplantation: comparison with BuCy2. Bone Marrow Transplant 2007; 40: 541–547.

    Article  CAS  PubMed  Google Scholar 

  32. Iravani M, Evazi MR, Mousavi SA, Shamshiri AR, Tavakoli M, Ashouri A et al. Fludarabine and busulfan as a myeloablative conditioning regimen for allogeneic stem cell transplantation in high- and standard-risk leukemic patients. Bone Marrow Transplant 2007; 40: 105–110.

    Article  CAS  PubMed  Google Scholar 

  33. Perez-Simon JA, Diez-Campelo M, Martino R, Brunet S, Urbano A, Caballero MD et al. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation. Br J Haematol 2005; 130: 394–403.

    Article  PubMed  Google Scholar 

  34. Kim DH, Sohn SK, Kim JG, Suh JS, Lee KS, Lee KB . Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation. Bone Marrow Transplant 2004; 33: 1025–1030.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology/Oncology, Kyungpook National University Hospital, Daegu, Korea

    J H Moon, S N Kim, B W Kang, Y S Chae, J G Kim & S K Sohn

  2. Chonnam National University Hwasun Hospital, Gwangju, Korea

    J S Ahn, Y K Kim, D H Yang, J J Lee & H J Kim

  3. Pusan National University Hospital, Busan, Korea

    Y J Choi, H J Shin, J S Chung & G J Cho

Authors
  1. J H Moon
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S N Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B W Kang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y S Chae
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J G Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J S Ahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Y K Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. D H Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. J J Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. H J Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Y J Choi
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. H J Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. J S Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. G J Cho
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. S K Sohn
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S K Sohn.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moon, J., Kim, S., Kang, B. et al. Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset. Bone Marrow Transplant 45, 1540–1545 (2010). https://doi.org/10.1038/bmt.2010.12

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2010.12

Keywords

This article is cited by

Search

Advanced search

Quick links